To determine if the emergency department (ED) setting offers a viable space for improving HPV vaccination coverage among 18 to 45-year-old adults who have not yet received human papilloma virus (HPV) vaccination or who did not complete the vaccine series. This study will develop, pilot and evaluate an ED-based HPV vaccination protocol and program for ED patients aged 18-26 (for whom catch-up HPV vaccination is routinely recommended by the CDC) and separately for patients aged 27-45 (for whom it may be recommended under shared decision making, SDM).
Study Type
OBSERVATIONAL
Enrollment
34
Prevent HPV-associated diseases and cancers
University of Alabama at Birmingham
Birmingham, Alabama, United States
Number of study participants who receive HPV vaccination at baseline
HPV vaccination will be administered at the time of the study participant's initial visit (baseline)
Time frame: Baseline
Number of study participants who receive HPV vaccination at 2 months
Number of study participants receiving dose 2 of the HPV vaccination series 2 months after initial study visit
Time frame: 2 months
Number of study participants who receive HPV vaccinations at 6 months
Number of study participants receiving dose 3 of the HPV vaccination series 6 months after initial study visit
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.